CUSIP: 128058203
Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
9,424,813
-
Share change
-
+622,145
-
Total reported value
-
$4,997,005
-
Put/Call ratio
-
0%
-
Price per share
-
$0.53
-
Number of holders
-
26
-
Value change
-
+$305,813
-
Number of buys
-
11
-
Number of sells
-
12
Quarterly Holders Quick Answers
What is CUSIP 128058203?
CUSIP 128058203 identifies CLBS - CALADRIUS BIOSCIENCES INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2022
-
Previous quarter:
Q1 2022
Recent filing periods for CUSIP 128058203:
Institutional Holders of CALADRIUS BIOSCIENCES INC - COM NEW (CLBS) as of Q2 2022
As of 30 Jun 2022,
CALADRIUS BIOSCIENCES INC - COM NEW (CLBS) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,424,813 shares.
The largest 10 holders included
VANGUARD GROUP INC, SABBY MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, IPG Investment Advisors LLC, NORTHERN TRUST CORP, and TWO SIGMA ADVISERS, LP.
This page lists
26
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.